Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Gastroenterology. Author manuscript; available in PMC 2010 April 1.
Published in final edited form as:
PMCID: PMC2695717

Intestinal Vitamin D Receptor is Required for Normal Calcium and Bone Metabolism in Mice


Background & Aims

Vitamin D Receptor (VDR)-knockout mice develop severe hypocalcaemia and rickets, accompanied by disruption of active intestinal calcium absorption. To specifically study the effects of VDR in intestinal Ca absorption, we investigated whether restoration of intestinal VDR is sufficient to recover the phenotype of VDR-knockout mice.


We generated mice with intestine-specific transgenic expression of human VDR and crossed them to VDR knockout mice. The intestine, kidney and bone phenotypes of the VDR-knockout mice with intestine-specific expression of human VDR (KO/TG) were analyzed.


Transgenic expression of VDR in the intestine of VDR-knockout mice normalized duodenal vitamin D-regulated calcium absorption as well as vitamin D-regulated calbindin D9k and TRPV6 gene expression in the duodenum and proximal colon. As a result, animal growth and the serum levels of calcium and parathyroid hormone were normalized in KO/TG mice. Other phenotypes were revealed when calcium metabolism was normalized in KO/TG mice: serum 1,25 dihydroxyvitamin D levels were higher in KO/TG mice than normal mice, due to reduced renal expression of the vitamin D-degrading enzyme CYP24; urinary calcium excretion was higher and associated with lower renal calbindin D9k and D28k than normal mice; and bone density and volume increased in KO/TG compared with normal mice, due to increased mineral apposition rate and osteoblast number.


Intestinal VDR and vitamin D-regulated intestinal calcium absorption are critical for controlling whole-body calcium metabolism in growing mice. Normalizing intestinal calcium absorption and metabolism reveals essential roles for VDR in control of bone formation, renal control of serum 1,25(OH)2D and urinary calcium excretion.


The active hormonal form of vitamin D, 1,25 dihydroxyvitamin D3, (1,25(OH)2D), is a major regulator of calcium (Ca) metabolism.1 Elevated circulating 1,25(OH)2D levels activate the vitamin D receptor (VDR) leading to increased intestinal Ca absorption, reduced renal Ca excretion, and elevated bone resorption.2, 3 VDR is a nuclear hormone receptor superfamily member that mediates 1,25(OH)2D function by heterodimerizing with the retinoid X receptor (RXR) and interacting with response elements on target genes whose protein products mediate Ca metabolism, e.g. an apical membrane calcium channel, the transient receptor potential cation channel, subfamily V, member 6 (TRPV6) and the calcium binding protein calbindin D9K3, 4 proposed to be involved in intestinal Ca absorption.5

Intestinal Ca absorption occurs through both passive paracellular and active transcellular pathways; only the active pathway is regulated by 1,25(OH)2D.6, 7 We9 and others10 have previously shown that deletion of VDR in mice leads to a dramatic loss in active intestinal Ca absorption efficiency (>70%) as well as reduced expression of the molecular markers of intestinal Ca absorption, calbindin D9K (down 55%) and TRPV6 (down 90%). However, feeding a rescue diet with 2% Ca, 1.25% phosphate, and 20% lactose that bypasses the transcellular Ca absorption pathway can partially prevent the phenotype of VDR knockout (KO) mice 8-12. This suggests that a primary role for VDR and 1,25(OH)2D in the control of Ca metabolism is to maintain high rates of active intestinal Ca absorption. To directly test this hypothesis we created a transgenic mouse with expression of a hemaglutinin (HA)-tagged human VDR (HA-hVDR) limited to the intestine using the villin promoter/enhancer.13 We found that transgenic hVDR expression restores Ca homeostasis and vitamin D-related intestinal functions as well as prevents the rachitic phenotype of KO mice. In addition, by normalizing Ca metabolism, our data reveal important functions for VDR in the kidney and bone. These studies support the hypothesis that intestinal VDR and vitamin D-regulated intestinal Ca absorption are central for controlling whole body Ca metabolism during growth.

Materials and Methods


All animal experiments were approved by the Purdue Animal Care and Use Committee. Mice were housed individually, exposed to a 12-h light/12-h dark cycle, and given standard chow diet containing 0.72% calcium and water ad libitum. VDR knockout mice (KO)14 were maintained as heterozygous females (VDR +/-) and KO males for breeding.11

Generation of HA-hVDR Expressing Transgenic Mice

The transgene construct and the methods for generating the transgenic mice are included in the supplementary information online at

The transgene was detected in tail genomic DNA by conventional PCR and the transgene copy number was determined using real-time PCR.

Characterization of Transgenic Mice

Transgene Tissue Distribution and Expression Level

Total RNA was isolated with Tri-reagent (Molecular Research Center Inc, Cincinnati, OH) from various tissues of 2-mo-old wild type (WT) mice and transgenic mice (TG +/−) with low (TG(L)) or high (TG(H)) transgene expression and reverse-transcribed into cDNA as previously described.15

VDR protein levels from intestinal segments were evaluated in samples extracted (PRO-PREP™ protein extraction buffer, iNtRON Biotechology, Inc., Gyeonggi-do, Korea) from 2 centimeters of each intestinal segment in WT and TG(H) mice after culture in DMEM plus 10% FBS for 2 h at 37°C, in 5% CO2, 95% air. Western blot analysis using an anti-VDR primary antibody was used to detect the natural and transgenic VDR protein (see supplementary information online at

Evaluation of the Phenotype of Transgenic Mice

Serum calcium, phosphate, and 1,25(OH)2D, and bone mineral density (BMD) from 2-month-old, gender-matched WT and TG(L) or TG(H) mice fed chow diet were determined as described in the supplementary information online at (n=8 each genotype).

Development and Characterization of VDR Knockout Mice Expressing the Villin-HA-hVDR Transgene

The experimental mice of four genotypes were obtained by pairing KO mice (VDR-/-, TG-/-) and VDR+/-, TG+/- mice: VDR+/-, KO, or KO mice with intestine-specific TG expression (KO/TG(L) and KO/TG(H)). VDR +/-, KO or KO/TG mice used for experiments were littermates and VDR+/- mice were used as controls because they are phenotypically normal when fed a nutritionally adequate diet.14, 18 Experimental mice were fed the standard chow diet for either 8 wk (female) or 12 wk (male).

12-wk-old male mice were used for basal analysis (n=8 per group). Serum was prepared for analysis of calcium, phosphate, parathyroid hormone, and 1,25(OH)2D levels. Urine was taken directly from the bladder for assessment of calcium to creatinine ratio. Mucosal scrapings from duodenum and proximal colon, and kidneys were harvested for analysis of gene expression (see below). Thyroid-parathyroid tissue and femora was harvested, fixed in 10% neutral buffered formalin for 12 h and 7 days, respectively, and stored in 75% ethanol at 4°C until the samples were processed.

8-wk-old female mice were fasted overnight and then treated with vehicle (a 1:9 mixture of ethanol:propylene glycol) or 1,25(OH)2D (25 ng or 100 ng /100 g body weight in 0.1 ml vehicle) by i.p. injection. 9 h later mice were studied for intestinal calcium absorption (25 ng dose only) using in situ loops of duodenum (2 cm from polyric sphincter, 2 mM total calcium),16 as well as renal and intestinal gene expression (n=6-8 per treatment per genotype group).

Bone modeling dynamics were assessed by double calcein labeling in 8-wk-old female VDR+/-, KO and KO/TG(H) mice injected i.p. with 20 mg calcein /g body weight in PBS (Sigma Chemical, St Louis, MO) on the 10th day and 3rd day before termination of the experiment (n= 7 per genotype).17 Femurs were removed and cleaned of all soft tissue, fixed in 75% ethanol at 4°C until embedding in methyl methacrylate at low temperature.

Primers and PCR cycle conditions, analysis of tissues (bone densitometry, tomography, histology) and serum (calcium, phosphate, 1,25(OH)2D, PTH), image quantification, and statistical analysis are included in the supplemental online information.


Generation and Characterization of Intestine-specific hVDR Transgenic Mice

Transgenic mice expressing HA-hVDR under control of the villin promoter/enhancer were generated (Figure 1A). Four founders were identified (three are shown in Figure 1B) and the lines with 10 (TG(L)) and 50 (TG(H)) copies of the transgene were characterized further. Transgene mRNA was detectable throughout the intestine (Figure 1C, 1D); total VDR mRNA level in duodenum was increased by 4- and 20-fold in TG(L) and TG(H), respectively (Figure 2A). A small amount of transgene mRNA was expressed in the kidney but this had no impact on total VDR mRNA levels (Figure 2B). All other tissues were transgene negative (Figure 1D).

Figure 1
Generation of intestine-specific, human VDR expressing, transgenic mice
Figure 2
Characterization of transgene mRNA and protein levels in two transgenic lines

VDR was present in all segments of the intestine with the highest levels seen in the cecum and colon (Figure 2D). Transgene expression increased VDR protein level throughout the intestine with the highest expression in the small intestine (Figure 2D; e.g. 2 and 8- fold higher in TG(L) and TG(H) mice than wild type (WT) mice in duodenum, respectively Figure 2C). At 2 mo, all transgenic mice were healthy, fertile and grew normally. No differences were observed between the TG lines and WT mice for serum Ca, phosphate, 1,25(OH)2D or bone mineral density (data not shown) .

Gross Appearance, Growth Curves, and Serum Phenotype

12-wk-old male KO mice had alopecia and were growth arrested when grown on a chow diet. The growth arrest of KO mice was prevented in both KO/TG(L) and KO/TG(H) transgenic lines but the alopecia remained (Figure 3A, 3B). KO mice also had hypocalcemia (44% lower than VDR+/-, Figure 3C a) and hyperparathyroidism (84-fold higher serum PTH, Figure 3C b, enlarged parathyroid glands, Figure 3C c). In KO/TG(L) and KO/TG(H), serum Ca, serum PTH, and parathyroid gland size were normalized (Figure 3C).

Figure 3
Gross appearance, growth curves and serum chemistries of VDR+/-, KO, KO/TG mice

Intestinal Phenotype

Basal duodenal Ca absorption was 53% lower in 8-wk-old female, chow-fed KO mice than VDR+/- mice. In KO/TG(H) mice, Ca absorption was not only restored, it was 26% higher than VDR+/- mice (Figure 4A a). Similarly, duodenal calbindin D9k and TRPV6 mRNA levels were significantly reduced in KO mice (i.e. by 93% and 99% compared to VDR+/- mice, respectively) and transgenic recovery of intestinal VDR increased their levels above that seen in VDR+/- mice by 150% (calbindin D9k) and 67% (TRPV6)(Figure 4A c). 1,25(OH)2D treatment increased duodenal Ca absorption by 70% in VDR+/- mice (to 51.7±2.9%), had no impact in KO mice, and increased Ca absorption by 40% in KO/TG(H) mice (to 52.5±4.0%, Figure 4A a). Both 25 ng and 100 ng/100 g body weight (BW) 1,25(OH)2D doses significantly induced duodenal CYP24, calbindin D9k and TRPV6 mRNA expression in VDR+/- but not in KO mice. KO/TG(H) mice responded to treatment but the induction was blunted for CYP24 and TRPV6 mRNA (Figure 4A b, c).

Figure 4
Intestinal phenotype of VDR+/-, KO and KO/TG mice

Similar findings to those in the duodenum were observed in the proximal colon. Calbindin D9k and TRPV6 mRNA levels were nearly eliminated in KO mice and their expression was recovered in the proximal colon of KO/TG mice (Figure 4B a). Like we observed in the duodenum, 1,25(OH)2D-responsive expression of calbindin D9k and TRPV6 mRNA was restored in KO/TG but the response was blunted compared to VDR +/- mice (Figure 4B b).

Renal Phenotype

Chow-fed KO mice had higher serum 1,25(OH)2D (98-fold) and renal CYP27B1 mRNA (400-fold) than VDR+/- mice at 12 wk. Renal CYP24 mRNA was undetectable in KO mice. Compared to KO mice serum 1,25(OH)2D was significantly reduced in KO/TG(L) and KO/TG(H) mice but it was still 40- and 6-fold higher than VDR +/- mice, respectively (Figure 5A a). Renal CYP27B1 mRNA was 12-fold higher in KO/TG(L) than VDR +/- mice but was normalized in KO/TG(H) mice. In contrast, renal CYP24 mRNA was 95% and 75% lower than VDR+/- mice in KO/TG(L) and KO/TG(H) mice, respectively (Figure 5A b).

Figure 5
Renal phenotypes of VDR+/-, KO and KO/TG mice

Renal Ca excretion was lower in chow-fed KO mice, presumably due to reduced serum Ca levels. Normalizing serum Ca revealed a significant increase in urinary Ca (248% higher in KO/TG(H) mice than VDR+/- mice, Figure 5A c). Renal calbindin D9k and calbindin D28k mRNA levels were significantly reduced in KO mice (by 90% and 50% compared to VDR+/- mice, respectively) and their levels were not recovered in KO/TG(H) mice (Figure 5A d). Neither renal TRPV5 nor TRPV6 mRNA levels were altered in either KO or KO/TG(H) mice (data not shown).

In VDR +/- mice 1,25(OH)2D-treatment (25 ng/100g BW) had no impact on renal calbindin D9k, calbindin D28k, or TRPV6 mRNA (data not shown). Renal CYP24 mRNA was strongly induced in VDR+/- mice (270-fold), was not affected in KO, and was blunted in KO/TG(H) (4–fold increase, Figure 5B a). 1,25(OH)2D suppressed renal CYP27B1 gene expression by 99% and induced renal TRPV5 gene expression by 2.8-fold in VDR+/- mice but these effects were not observed in either KO or KO/TG(H) mice (Figure 5B b, c).

Skeletal Phenotype

Femurs were significantly shorter in KO mice but length was normalized in KO/TG(L) and KO/TG(H) mice (data not shown). Femur bone mineral density (BMD) was decreased by 56% in KO mice. In KO/TG(L) and KO/TG(H) mice, BMD was not only restored, it was increased 14% above the level seen in VDR+/- mice (Figure 6A). Similarly, radiographs reveal that the density in the epiphysis, metaphysis and diaphysis of KO mouse femur was reduced and this was prevented in KO/TG(H) mice (Figure 6B). pQCT analysis of the femur midshaft showed that total bone area, cortical bone area, and polar moment of inertia (IP) were decreased by 33%, 90% and 42%, respectively, in KO mice. In the distal femur, total bone area and trabecular bone area were decreased by 32% and 39%. In KO/TG(H) mice total bone area, cortical bone area and IP in the midshaft of femur were increased (by 18%, 13% and 37%, respectively) and total bone area and trabecular bone area in the distal femur was elevated (by 17% and 18%, respectively) relative to VDR+/- mice (Table 1).

Figure 6
Skeletal phenotype of VDR+/-, KO, KO/TG(L) and KO/TG(H) mice
Table 1
Mid-shaft and Distal Femur pQCT Parameters

KO mice had disorganized, widened and expanded growth plates and this was completely prevented in KO/TG(H) mice (H&E staining not shown but collagen staining reveals this in Figure 7A). Trabecular bone volume (by total collagen staining) was increased by 113% in KO mice compared to VDR+/- mice. In KO/TG(H) mice trabecular bone volume was still 23% higher than that seen in VDR+/- mice (Figure 7A, 7F a). Osteoid volume (by von Kossa staining) was 13-fold higher in KO mice compared to VDR+/- mice but this was normalized in KO/TG(H) mice (Figure 7B, 7F b). Thus, while the increased trabecular bone volume in KO was due to more unmineralized bone, the increase in KO/TG(H) was due to new bone formation. This conclusion was supported by our examination of mineral apposition rate (MAR). While there was a lack of distinct calcein labeling in KO mice, distinct labeling was restored in KO/TG(H) mice and MAR was 2-fold higher than in VDR+/- mice (Figure 7C, 7F c).

Figure 7
Static and dynamic histomorphormetric analysis of VDR+/-, KO and KO/TG(H) mice

Tartrate Resistant Acid Phosphatase (TRAP) positive osteoclast number was not influenced by VDR status (Figure 7E, 7F e). However, there was a 2-fold increase in osteoblast number in KO mice compared to VDR+/- mice. In KO/TG(H) mice, osteoblast number was reduced compared to KO mice but was still 40% higher than VDR+/- mice (Figure 7D, 7F d).


The creation of VDR KO mice confirmed the critical role that VDR plays in the control of whole body Ca metabolism.14, 18, 19 Using these mice, we11 and others19 found that transcellular intestinal Ca absorption was disrupted (e.g. 70% lower at 2 months) and was accompanied by lower levels of the molecular markers for active Ca absorption (e.g. calbindin D9k mRNA 50% lower; TRPV6 mRNA >90% lower). By-passing active, vitamin D-dependent Ca absorption with high Ca, high lactose diets can prevent hypocalcemia and development of osteomalacia and rickets seen in KO mice.8-10 Collectively, these data suggest that controlling active intestinal Ca absorption is the central role that VDR plays in Ca metabolism during growth. Our research directly tests this hypothesis; we have now demonstrated that the restoration of VDR throughout the intestine of KO mice is sufficient to recover the phenotype of disrupted Ca metabolism in these animals. In addition, our research reveals several interesting aspects regarding the regulation of Ca metabolism across the three tissue axis of intestine, kidney, and bone whose activities are normally coordinated to regulate Ca metabolism.

Our data suggest that the lower bowel is a more important site for vitamin D-regulated Ca absorption than previously appreciated. Earlier work by Pansu et al. found vitamin D-regulated, transcellular Ca absorption in the duodenum but not the distal ileum of rats,7 thereby identifying the proximal small intestine as the most important site for vitamin D-regulated Ca absorption. However, intestinal VDR levels are high in the cecum and colon of mice (Figure 2D) and this is accompanied by vitamin D regulated expression of TRPV6 and calbindin D9k mRNA (Figure 4B and data not shown). In KO mice, calbindin D9k and TRPV6 mRNA levels in the colon and cecum are severely reduced (Figure 4B, data not shown) and transgenic recovery of VDR in the large intestine of KO mice restored expression of these genes in the colon (Figure 4B a). Also, Fujita et al. 20 have recently reported that vitamin D-regulated expression of claudins-2 and 12 in the jejunum, ileum, and colon may modulate paracellular Ca absorption. These findings suggest that Ca absorption is regulated by vitamin D-mediated mechanisms in the lower intestinal segments, where long residence times21 would permit a significant amount of Ca absorption even if the rate of active/passive transport or the solubility of Ca was low. This is consistent with reports that net Ca absorption increases in the ileum22 and colon23 of people treated with 1,25(OH)2D and that active 1,25(OH)2D-regulated Ca absorption is seen in isolated segments of the cecum24 and colon25, 26 from rats. The importance of active 1,25(OH)2D-regulated Ca absorption in the lower intestine is also consistent with our earlier report showing that although the adenosine deaminase (ADA) promoter-driven transgenic expression of hVDR to the distal duodenum and proximal jejunum of KO mice could restore 1,25(OH)2D-mediated Ca absorption in those sections, this was not sufficient to maintain whole body Ca homeostasis on a commercial chow diet (27 and additional unpublished data).

Recent knockout mouse studies show that calbindin D9k is not essential for vitamin D-regulated intestinal Ca absorption,28, 29 but our studies show that it continues to correlate well with it; both duodenal calbindin D9k mRNA and Ca absorption levels were elevated in KO/TG(H) mice (150% and 26% higher than VDR+/-, respectively) and both were significantly elevated by 1,25(OH)2D treatment (Figure 4A a, c). In contrast, the response of duodenal TRPV6 and CYP24 mRNA to 1,25(OH)2D treatment was blunted in intestinal segments from KO/TG mice relative to VDR +/- mice. Although we cannot account for this effect, the disconnect between induction of Ca absorption by exogenous 1,25(OH)2D and TRPV6 mRNA is consistent with several reports that show vitamin D-regulated Ca absorption can occur in the absence of TRPV6.30, 31

Our HA-hVDR transgene was also expressed in the kidney. However, transgene expression did not increase total VDR mRNA in the kidney of normal mice suggesting the level of expression was low. Others have shown that the villin promoter drives gene expression in the epithelial cells of the renal proximal tubule but not distal tubule32, 33 where VDR,34, 35 CYP27B1,36 and 1,25(OH)2D-mediated renal Ca reabsorption are observed.37 The lack of 1,25(OH)2D-mediated regulation of CYP24, TRPV5, and CYP27B1 mRNA in the kidney of KO/TG mice indicates that these mice are still VDR-deficient in the normally vitamin D-responsive distal tubule and that they can be used to reveal other interesting phenotypes related to renal vitamin D action and metabolism. For example, we found that serum 1,25(OH)2D levels were not fully recovered in KO/TG mice even though serum Ca and PTH were normalized. In KO mice, VDR inactivation increased renal CYP27B1 mRNA and serum 1,25(OH)2D level. However, even when CYP27B1 mRNA was normalized in KO/TG(H) kidney, serum 1,25(OH)2D was still elevated. We believe that this is because renal CYP24 mRNA expression was still 75% lower than normal in KO/TG(H). These data suggest that circulating 1,25(OH)2D levels are dependent upon the balance between 1,25(OH)2D production mediated by CYP27B1 in the kidney and CYP24-mediated degradation there.

Another interesting renal phenotype we observed in KO/TG mice was that the urinary Ca:creatinine ratio was increased by nearly 3-fold compared to VDR +/- mice. This is consistent with Li et al.38 who found that urinary Ca excretion was 2-fold higher in KO mice compared to wild type mice when both were fed a high Ca rescue diet. These data suggest that the normalization of serum Ca in KO mice reveals a defect in the Ca reabsorption machinery of KO mouse kidney. We saw that renal calbindin D9k and calbindin D28k mRNA levels were significantly reduced in KO mice (by 95% and 50%, respectively) and that this was not restored in the KO/TG(H) mice (Figure 5A d). These proteins have previously been shown to be critical for renal Ca reabsorption.39-41

The final VDR function revealed by our KO/TG mouse is related to bone. We found that bone density and volume in KO/TG(H) mice fed a high calcium chow diet were not only normalized but were increased relative to VDR+/- mice. This was due to a significant increase in MAR and osteoblast number in the KO/TG mouse bone (Figure 7). This suggests that the predominant role for VDR in the growing mouse bone is to suppress bone formation. This conclusion is consistent with previous studies by Tanaka et al. who reported that femur from VDR knockout mice formed more bone when transplanted into wild type mice42 as well as Sooy et al.43 who found that calvarial osteoblasts from KO mice displayed enhanced osteogenesis in vitro. As Sooy et al. speculated in their report, this is likely due to the suppressive effects that 1,25(OH)2D has on expression of the runt-related transcription factor 2 (Runx2),44 a critical regulator of osteoblast differentiation.45 The increase of bone mineralization and volume we observed in KO/TG has not been observed in VDR knockout mice after normalization of ion homeostasis by feeding a high Ca/high lactose rescue diet.8-12 We believe that this is because the rescue diet is traditionally fed after the development of secondary hyperparathyroidism in VDR knockout offspring.

In summary, our data show the critical importance of intestinal VDR and vitamin D-regulated Ca absorption for the control of whole-body Ca metabolism during growth, a time when Ca needs are maximal. Intestine-specific recovery of VDR completely normalized serum Ca, serum PTH, bone growth, and bone mineralization. In addition, our model reveals critical functions of VDR in bone and kidney, i.e. suppression of osteoblast formation and bone growth, renal control of circulating 1,25(OH)2D levels and urinary Ca excretion. Because we have normalized Ca metabolism and growth in our KO/TG mice without the need to feed a special diet, we also believe our model will be a valuable tool to study the action of vitamin D in non-classical target organs. In addition to bone, intestine, and kidney, VDR is present in many other tissues including prostate, breast, pancreas, skin, reproductive organs, adipose tissue, and muscle (both cardiac and skeletal).46, 47 Using our KO/TG(H) mouse to study the role of VDR in these tissues without the confounding influence of disrupted Ca metabolism or growth will permit researchers to directly test the mechanistic foundation for the proposed relationships between vitamin D status and the prevention of cancer, diabetes, hypertension, and other chronic diseases.48

Supplementary Material


This work was supported by NIH awards DK054111 and CA101113 to JCF.

The authors would like to thank: Purdue University: Ms. Katherine Barzan-Smith and Ms. Rebecca McCreedy (Department of Foods and Nutrition, organ harvests), Ms. Yan Sun and Dr. Steve Konieczny (Department of Biology, histology), Dr. John Turek (School of Veterinary Medicine, collection of histological images). Indiana University School of Medicine: Mr. Qiwei Sun and Dr. Charles Turner (bone densitometry and pQCT); University of Tokyo: Dr. Shigeaki Kato for mVDR knockout mice; University of Michigan: Dr. Debra Gumucio for pUC12.4kb-villin plasmid, and Case Western Reserve University: Dr. Paul N. McDonald for pCDNA3.1-HA-hVDR plasmid.


calbindin D9k
calcium binding protein D9k
calbindin D28K
calcium binding protein D28K
VDR knockout
parathyroid hormone
transient receptor potential cation channel, subfamily V, member 6
transient receptor potential cation channel, subfamily V, member 5
vitamin D receptor
wild type
1 alpha, 25 dihydroxyvitamin D3


Conflicts of interest: There are no conflicts of interest to disclose.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Reference List

1. Fleet JC. Molecular Regulation of Calcium Metabolism. In: Weaver CM, Heaney RP, editors. Calcium in Human Health. Totowa, NJ: Humana Press; 2006. pp. 163–190.
2. Wood RJ, Fleet JC, Cashman K, et al. Intestinal calcium absorption in the aged rat: evidence of intestinal resistance to 1,25(OH)2 vitamin D. Endocrinology. 1998;139:3843–3848. [PubMed]
3. Song Y, Peng X, Porta A, et al. Calcium transporter 1 and epithelial calcium channel messenger ribonucleic acid are differentially regulated by 1,25 dihydroxyvitamin D3 in the intestine and kidney of mice. Endocrinology. 2003;144:3885–3894. [PubMed]
4. Meyer MB, Watanuki M, Kim S, et al. The human transient receptor potential vanilloid type 6 distal promoter contains multiple vitamin D receptor binding sites that mediate activation by 1,25-dihydroxyvitamin D3 in intestinal cells. Mol Endocrinol. 2006;20:1447–1461. [PubMed]
5. Bronner F, Pansu D, Stein WD. An analysis of intestinal calcium transport across the rat intestine. Am J Physiol. 1986;250:G561–G569. [PubMed]
6. Giuliano AR, Wood RJ. Vitamin D-regulated calcium transport in Caco-2 cells: unique in vitro model. Am J Physiol. 1991;260:G207–G212. [PubMed]
7. Pansu D, Bellaton C, Roche C, et al. Duodenal and ileal calcium absorption in the rat and effects of vitamin D. Am J Physiol. 1983;244:695–700. [PubMed]
8. Amling M, Priemel M, Holzmann T, et al. Rescue of the skeletal phenotype of vitamin D receptor ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analysis. Endocrinology. 1999;140:4982–4987. [PubMed]
9. Li YC, Amling M, Pirro AE, et al. Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology. 1998;139:4391–4396. [PubMed]
10. Masuyama R, Nakaya Y, Katsumata S, et al. Dietary calcium and phosphorus ratio regulates bone mineralization and turnover in vitamin D receptor knockout mice by affecting intestinal calcium and phosphorus absorption. J Bone Miner Res. 2003;18:1217–1226. [PubMed]
11. Song Y, Kato S, Fleet JC. Vitamin D Receptor (VDR) Knockout Mice Reveal VDR-Independent Regulation of Intestinal Calcium Absorption and ECaC2 and Calbindin D9k mRNA. J Nutr. 2003;133:374–380. [PubMed]
12. Panda DK, Miao D, Bolivar I, et al. Inactivation of the 25-hydroxyvitamin D 1alpha-hydroxylase and vitamin D receptor demonstrates independent and interdependent effects of calcium and vitamin D on skeletal and mineral homeostasis. J Biol Chem. 2004;279:16754–16766. [PubMed]
13. Madison BB, Dunbar L, Qiao XT, et al. Cis elements of the villin gene control expression in restricted domains of the vertical (crypt) and horizontal (duodenum, cecum) axes of the intestine. J Biol Chem. 2002;277:33275–33283. [PubMed]
14. Yoshizawa T, Handa Y, Uematsu Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 1997;16:391–396. [PubMed]
15. Fleet JC, Wood RJ. Specific 1,25(OH)2 D3-mediated regulation of transcellular calcium transport in Caco-2 cells. Am J Physiol. 1999;276:G958–G964. [PubMed]
16. Song Y, Fleet JC. 1,25 dihydroxycholecalciferol-mediated calcium absorption and gene expression are higher in female than in male mice. J Nutr. 2004;134:1857–1861. [PubMed]
17. Xue YB, Karaplis AC, Hendy GN, et al. Genetic models show that parathyroid hormone and 1,25-dihydroxyvitamin D-3 play distinct and synergistic roles in postnatal mineral ion homeostasis and skeletal development. Hum Mol Genet. 2005;14:1515–1528. [PubMed]
18. Li YC, Pirro AE, Amling M, et al. Targeted ablation of the vitamin D receptor: An animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA. 1997;94:9831–9835. [PubMed]
19. Van Cromphaut SJ, Dewerchin M, Hoenderop JG, et al. Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci U S A. 2001;98:13324–13329. [PubMed]
20. Fujita H, Sugimoto K, Inatomi S, et al. Tight junction proteins claudin-2 and -12 are critical for vitamin D-dependent Ca2+ absorption between enterocytes. Mol Biol Cell. 2008;19:1912–1921. [PMC free article] [PubMed]
21. Pansu D, Duflos C, Bellaton C, et al. Solubility and intestinal transit time limit calcium absorption in rats. J Nutr. 1993;123:1396–1404. [PubMed]
22. Krejs GJ, Nicar MJ, Zerwekh JE, et al. Effect of 1,25-dihydroxyvitamin D3 on calcium and magnesium absorption in the healthy human jejunum and ileum. Am J Med. 1983;75:973–976. [PubMed]
23. Grinstead WC, Pak CYC, Krejs GJ. Effect of 1,25-Dihydroxyvitamin-D3 on Calcium-Absorption in the Colon of Healthy Humans. Am J Physiol. 1984;247:G189–G192. [PubMed]
24. Karbach U, Feldmeier H. The cecum is the site with the highest calcium absorption in rat intestine. Dig Dis Sci. 1993;38:1815–1824. [PubMed]
25. Favus MJ, Langman CB. Effects of 1,25 dihydroxyvitamin D3 on colonic calcium transport in vitamin D-deficient and normal rats. Am J Physiol. 1984;246:G268–G273. [PubMed]
26. Karbach U, Ewe K. Calcium and magnesium transport and influence of 1,25-dihydroxyvitamin D3. In vivo perfusion study at the colon of the rat. Digestion. 1987;37:35–42. [PubMed]
27. Marks HD, Fleet JC, Peleg S. Transgenic expression of the human Vitamin D receptor (hVDR) in the duodenum of VDR-null mice attenuates the age-dependent decline in calcium absorption. J Steroid Biochem Mol Biol. 2007;103:513–516. [PubMed]
28. Akhter S, Kutuzova GD, Christakos S, et al. Calbindin D9k is not required for 1,25-dihydroxyvitamin D3-mediated Ca2+ absorption in small intestine. Arch Biochem Biophys. 2007;460:227–232. [PubMed]
29. Kutuzova GD, Akhter S, Christakos S, et al. Calbindin D(9k) knockout mice are indistinguishable from wild-type mice in phenotype and serum calcium level. Proc Natl Acad Sci U S A. 2006;103:12377–12381. [PubMed]
30. Bianco SD, Peng JB, Takanaga H, et al. Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene. J Bone Miner Res. 2007;22:274–285. [PubMed]
31. Benn BS, Ajibade D, Porta A, et al. Active Intestinal Calcium Transport in the Absence of TRPV6 and Calbindin-D9k. Endocrinology. 2008;49:3196–3205. [PubMed]
32. Grone HJ, Weber K, Helmchen U, et al. Villin - A Marker of Brush-Border Differentiation and Cellular-Origin in Human Renal-Cell Carcinoma. Am J Pathol. 1986;124:294–302. [PubMed]
33. Braunstein EM, Qiao XT, Madison B, et al. Villin: A marker for development of the epithelial pyloric border. Dev Dyn. 2002;224:90–102. [PubMed]
34. Liu L, Ng M, Iacopino AM, et al. Vitamin D receptor gene expression in mammalian kidney. J Am Soc Nephrol. 1994;5:1251–1258. [PubMed]
35. Suh JM, Yu CT, Tang K, et al. The expression profiles of nuclear receptors in the developing and adult kidney. Mol Endocrinol. 2006;20:3412–3420. [PubMed]
36. Zehnder D, Bland R, Walker EA, et al. Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol. 1999;10:2465–2473. [PubMed]
37. Mensenkamp AR, Hoenderop JGJ, Bindels RJM. Recent advances in renal tubular calcium reabsorption. Curr Opin in Nephrol and Hy. 2006;15:524–529. [PubMed]
38. Li YC, Bolt MJ, Cao LP, et al. Effects of vitamin D receptor inactivation on the expression of calbindins and calcium metabolism. Am J Physiol Endocrinol Metab. 2001;281:E558–E564. [PubMed]
39. Bouhtiauy I, Lajeunesse D, Christakos S, et al. Two vitamin D3-dependent calcium binding proteins increase calcium reabsorption by different mechanisms II. Effect of CaBP 9k. Kidney Int. 1994;45:469–474. [PubMed]
40. Bouhtiauy I, Lajeunesse D, Christakos S, et al. Two vitamin D3-dependent calcium binding proteins increase calcium reabsorption by different mechanisms. I. Effect of CaBP 28K. Kidney Int. 1994;45:461–468. [PubMed]
41. Zheng W, Xie Y, Li G, et al. Critical role of calbindin-D28k in calcium homeostasis revealed by mice lacking both vitamin D receptor and calbindin-D28k. J Biol Chem. 2004;279:52406–52413. [PubMed]
42. Tanaka H, Seino Y. Direct action of 1,25-dihydroxyvitamin D on bone: VDRKO bone shows excessive bone formation in normal mineral condition. J Steroid Biochem Mol Biol. 2004;89-90:343–345. [PubMed]
43. Sooy K, Sabbagh Y, Demay MB. Osteoblasts lacking the vitamin D receptor display enhanced osteogenic potential in vitro. J Cell Biochem. 2005;94:81–87. [PubMed]
44. Drissi H, Pouliot A, Koolloos C, et al. 1,25-(OH)(2)-vitamin D3 suppresses the bone-related Runx2/Cbfa1 gene promoter. Exp Cell Res. 2002;274:323–333. [PubMed]
45. Komori T. Runx2, a multifunctional transcription factor in skeletal development. J Cell Biochem. 2002;87:1–8. [PubMed]
46. Haussler MR. Vitamin D receptors: nature and function. Annu Rev Nutr. 1986;6:527–562. [PubMed]
47. Minghetti PP, Norman AW. 1,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuitry. FASEB J. 1988;2:3043–3053. [PubMed]
48. Peterlik M, Cross HS. Dysfunction of the vitamin D endocrine system as common cause for multiple malignant and other chronic diseases. Anticancer Res. 2006;26:2581–2588. [PubMed]